Concepedia
Statistics
Publications
17
Citations
459
H-Index
12
Active since
1984
Affiliations
Klinikum Konstanz(Current)
Technical University of Denmark
University of Konstanz
MS-Schramberg (Germany)
Novo Nordisk Foundation
R. Boer is an author at Klinikum Konstanz specializing in pharmacology, medicine, and molecular pharmacology.
Publications per year
1984–2023
Effects of the selective bisindolylmaleimide protein kinase C inhibitor GF 109203X on P-glycoprotein-mediated multidrug resistance
Volker Gekeler, R. Boer, Florian Überall et al. · British Journal of Cancer · 1996 · 119 citations · Full text
Medicine, Oncology, Pharmacology +12
The Specific Bisindolylmaleimide PKC-Inhibitor GF 109203X Efficiently Modulates MRP-Associated Multiple Drug Resistance
Volker Gekeler, R. Boer, W Ise et al. · Biochemical and Biophysical Research Communications · 1995 · 64 citations
Medicine, Oncology, Pharmacology +11
The affinity, selectivity and biological activity of telenzepine enantiomers
Christian Schudt, R. Boer, Manfrid Eltze et al. · European Journal of Pharmacology · 1989 · 35 citations
Medicine, Medicinal Chemistry, Pharmacology +9
Reversible Labeling of a Chemosensitizer Binding Domain of p-Glycoprotein with a Novel 1,4-Dihydropyridine Drug Transport Inhibitor<sup>,</sup>
R. Boer, Manfred Dichtl, Christoph H. Borchers et al. · Biochemistry · 1996 · 31 citations
Medicine, Medicinal Chemistry, Pharmacology +16
Photoaffinity labeling of the V1 vasopressin receptor in plasma membranes from rat liver.
R. Boer, Falk Fahrenholz · Journal of Biological Chemistry · 1985 · 27 citations · Full text
Medicine, Biochemistry, Pharmacology +13
1–5 of 17